Instituut voor Neuropathische Pijn
English articles Management of diabetic painful neuropathy
| Management of diabetic painful neuropathy |
|
More than 20 million Americans, representing around 7% of the population, have diagnosed or undiagnosed diabetes, and diabetic polyneuropathy (DPN) is a well known complication and contributes up to nearly 1/3 of all the direct medical costs associated with diabetes. Around 1/5 of all patients with DPN are suffering from neuropathic pain. How are these patients treated and followed?
Written questionnaires were distributed to healthcare professionals at multiple New England locations between January and November 2006. The survey focussed on general questions about practices and included questions about the identification of painful DPN, as well as questions about treatments. 357 providers completed the questionnaire, representing an 80% response. In this survey, 11/3 of all participants that used NSAIDs. This is somewhat better than in other studies, as NSAIDs are known to be ineffective in neuropathic pan. In other previous studies 41% of 140 patients, 47% of 255 patients and 40% in 6000 patients received NSAIDs. Given that providers know that painful DPN adversely impacts their patients’ quality of life, it was surprising that only 70% of all therapists assessed the effectiveness of therapy at least frequently and only 22% assessed therapy at every visit. [1] Jan M. Keppel Hesselink, MD, PhD, april 2010
Referenties[1]: Possidente CJ, Tandan R. | A survey of treatment practices in diabetic peripheral neuropathy. | Prim Care Diabetes. | 2009 Nov;3(4):253-7. Epub 2009 Oct 4. |